Latest Breaking News On - Hyundai bioscience - Page 1 : comparemela.com

Hyundai Bioscience Announces Clinical Development Plan for Niclosamide-based Metabolic Anticancer Drug Targeting P53 Mutation Cancer

/PRNewswire/ Hyundai Bioscience announced on April 25th that its clinical development plan of oral "Niclosamide Metabolic Anticancer Drug" targeting cancer.

South-korea
Seoul
Soult-ukpyolsi
Joobin-jung
Adm
Metabolic-anticancer
Hyundai-bioscience
Leon-lim

Hyundai Bioscience's antiviral for Dengue Fever to enter clinical trials in Brazil

/PRNewswire/ Hyundai Bioscience announced on April 25th that, after multiple consultations with global clinical research organizations (CRO), it has decided.

Brazil
Seoul
Soult-ukpyolsi
South-korea
Rio-de-janeiro
Estado-do-rio
Brazilian
Kim-kyung
Joobin-jung
Development-of-dengue
World-health-organization
Southern-brazil

Hyundai Bioscience announces its successful result from a preclinical study of a Niclosamide-based oral anticancer drug to treat triple-negative breast cancer | Taiwan News

Hyundai Bioscience announces its successful result from a preclinical study of a Niclosamide-based oral anticancer drug to treat triple-negative breast cancer | Taiwan News
taiwannews.com.tw - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from taiwannews.com.tw Daily Mail and Mail on Sunday newspapers.

South-korea
Seoul
Soult-ukpyolsi
Jin-geun
Hyundai-bioscience
Jin-geun-woo

Global clinical development on Dengue antiviral candidate will start, Hyundai Bioscience strives to win emergency use authorization

/PRNewswire/ South Korea s biotechnology company Hyundai Bioscience (CEO Oh Sang-gi, www.hyundaibioscience.com) announced on April 15 that it would carry.

Thailand
Malaysia
South-korea
United-states
Puerto-rico
Bangladesh
Seoul
Soult-ukpyolsi
Singapore
Vietnam
Republic-of
Brazil

STAT Inhibitors Clinical Trial Analysis: Delveinsight Evaluates A Robust Pipeline As 22+ Influential Pharma Players To Set Foot In The Domain

STAT Inhibitors Clinical Trial Analysis: Delveinsight Evaluates A Robust Pipeline As 22+ Influential Pharma Players To Set Foot In The Domain
menafn.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from menafn.com Daily Mail and Mail on Sunday newspapers.

United-states
New-york
Sumitomo-pharma
Recludix-pharma
Otsuka-pharmaceutica
Accendatech-united-states-inc
Moleculin-biotech-inc
Neurobo-pharmaceuticals
Neurobo-pharmaceuticals-inc
Nasdaq
Androscience-corporation
Drug-administration